Benefits of using methimazole in comparison to hydroquinone in the treatment of Melasma

Detalhes bibliográficos
Autor(a) principal: Fernandes, Fernanda Novaes
Data de Publicação: 2021
Outros Autores: Vieira, Gisllainy Aguiar, Santos , Jeane Rocha
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/24038
Resumo: Facial hyperchromias are pigmentary disorders caused by an increase in melanin in a specific area of ​​the skin. Melasma is an acquired hyperchromia, clinically diagnosed, with a high rate of recurrence. Its etiopathogenesis is not fully known, including several factors that facilitate its appearance or aggravate the problem, including exposure to UV rays, genetics, pregnancy, hormonal therapies, among others. Treatment is still a challenge and for many years hydroquinone was one of the most used substances as a tyrosinase inhibitor, but it has many toxic and harmful effects on the skin and other organs. Some alternative treatments with other depigmenting agents, such as metthimazole, also for topical use, have been increasingly effective and with fewer side effects when compared to hydroquinone. This is a literature review study that consists of the existence of two objectives, which are to contextualize a problem and verify existing possibilities in the literature in the formation of the theoretical framework. Furthermore, it is a descriptive exploratory research. Articles that present melasma with the main theme and that have been published between 2009 and 2020 will be selected. Those articles published before 2009 and that have no connection with the topic will be excluded. Conclusion: the study concluded that methimazole use is safer and more effective when compared to hydroquinone, but has slower results. The importance of further research evaluating the safety and efficacy of topical methimazole use is emphasized.
id UNIFEI_bbcb58220b296ab611670d587cd10d3b
oai_identifier_str oai:ojs.pkp.sfu.ca:article/24038
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Benefits of using methimazole in comparison to hydroquinone in the treatment of MelasmaBeneficios del uso de metimazol en comparación con hidroquinona en el tratamiento del MelasmaBenefícios do uso do methimazole em comparação a hidroquinona no tratamento do MelasmaMetimazoleMelasmaHydroquinone.MetimazolMelasmaHidroquinona.MetimazolMelasmaHidroquinona.Facial hyperchromias are pigmentary disorders caused by an increase in melanin in a specific area of ​​the skin. Melasma is an acquired hyperchromia, clinically diagnosed, with a high rate of recurrence. Its etiopathogenesis is not fully known, including several factors that facilitate its appearance or aggravate the problem, including exposure to UV rays, genetics, pregnancy, hormonal therapies, among others. Treatment is still a challenge and for many years hydroquinone was one of the most used substances as a tyrosinase inhibitor, but it has many toxic and harmful effects on the skin and other organs. Some alternative treatments with other depigmenting agents, such as metthimazole, also for topical use, have been increasingly effective and with fewer side effects when compared to hydroquinone. This is a literature review study that consists of the existence of two objectives, which are to contextualize a problem and verify existing possibilities in the literature in the formation of the theoretical framework. Furthermore, it is a descriptive exploratory research. Articles that present melasma with the main theme and that have been published between 2009 and 2020 will be selected. Those articles published before 2009 and that have no connection with the topic will be excluded. Conclusion: the study concluded that methimazole use is safer and more effective when compared to hydroquinone, but has slower results. The importance of further research evaluating the safety and efficacy of topical methimazole use is emphasized.Las hipercromías faciales son trastornos pigmentarios causados ​​por un aumento de melanina en un área específica de la piel. El melasma es una hipercromía adquirida, diagnosticada clínicamente, con una alta tasa de recurrencia. Su etiopatogenia aún no se conoce del todo, incluyendo varios factores que facilitan su aparición o agravan el problema, entre ellos la exposición a los rayos UV, la genética, el embarazo, las terapias hormonales, entre otros. El tratamiento sigue siendo un desafío y durante muchos años la hidroquinona fue una de las sustancias más utilizadas como inhibidor de la tirosinasa, pero tiene muchos efectos tóxicos y nocivos sobre la piel y otros órganos. Algunos tratamientos alternativos con otros agentes despigmentantes, como el metimazol, también de uso tópico, han sido cada vez más eficaces y con menos efectos secundarios en comparación con la hidroquinona Se trata de un estudio de revisión de la literatura que consiste en la existencia de dos objetivos, los cuales son contextualizar un problema y verificar las posibilidades existentes en la literatura en la formación del marco teórico. Además, se trata de una investigación exploratoria descriptiva. Se seleccionarán los artículos que presenten melasma con el tema principal y que hayan sido publicados entre 2009 y 2020. Se excluirán aquellos artículos publicados antes de 2009 y que no tengan relación con el tema. El estudio concluyó que el uso de metimazol es más seguro y más efectivo en comparación con la hidroquinona, pero tiene resultados más lentos. Se enfatiza la importancia de que se investiguen más a fondos que evalúen la seguridad y eficacia del uso tópico de metimazol.As hipercromias faciais são distúrbios pigmentares causados por uma elevação da melanina em um determinado local da pele. O melasma é uma hipercromia adquirida, clinicamente diagnosticada, que apresenta grande índice de reincidência. Sua etiopatogenia ainda não é totalmente conhecida, incluindo diversos fatores que facilitam o seu aparecimento ou agravam o problema, entre eles estão a exposição a raios UV, genética, gestação, terapias hormonais, entre outros. O tratamento ainda é um desafio e por muitos anos a hidroquinona foi uma das substâncias mais utilizadas como inibidora de tirosinase, porém apresenta muitos efeitos tóxicos e nocivos para a pele e outros órgãos. Alguns tratamentos alternativos com outros despigmentantes, como o metthimazol, também de uso tópico, vem se mostrando progressivamente mais eficazes e com menos efeitos colaterais quando comparados a hidroquinona. Além disso, trata-se de uma pesquisa de caráter descritivo exploratório. Serão selecionados artigos que apresentem com temática principal o melasma e que tenham sido publicados entre os anos de 2009 a 2020, serão excluídos aqueles artigos publicados antes de 2009 e que não tenham ligação com o tema. O estudo concluiu que o uso do methimazol é mais seguro e efetivo quando comparado a hidroquinona, porém possui resultados mais lentos. Ressalta-se a importância de novas pesquisas que avaliem a segurança e eficácia do uso tópico de methimazol.Research, Society and Development2021-12-16info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2403810.33448/rsd-v10i16.24038Research, Society and Development; Vol. 10 No. 16; e473101624038Research, Society and Development; Vol. 10 Núm. 16; e473101624038Research, Society and Development; v. 10 n. 16; e4731016240382525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/24038/21126Copyright (c) 2021 Fernanda Novaes Fernandes; Gisllainy Aguiar Vieira; Jeane Rocha Santos https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFernandes, Fernanda NovaesVieira, Gisllainy AguiarSantos , Jeane Rocha2021-12-20T11:03:07Zoai:ojs.pkp.sfu.ca:article/24038Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:42:43.351183Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Benefits of using methimazole in comparison to hydroquinone in the treatment of Melasma
Beneficios del uso de metimazol en comparación con hidroquinona en el tratamiento del Melasma
Benefícios do uso do methimazole em comparação a hidroquinona no tratamento do Melasma
title Benefits of using methimazole in comparison to hydroquinone in the treatment of Melasma
spellingShingle Benefits of using methimazole in comparison to hydroquinone in the treatment of Melasma
Fernandes, Fernanda Novaes
Metimazole
Melasma
Hydroquinone.
Metimazol
Melasma
Hidroquinona.
Metimazol
Melasma
Hidroquinona.
title_short Benefits of using methimazole in comparison to hydroquinone in the treatment of Melasma
title_full Benefits of using methimazole in comparison to hydroquinone in the treatment of Melasma
title_fullStr Benefits of using methimazole in comparison to hydroquinone in the treatment of Melasma
title_full_unstemmed Benefits of using methimazole in comparison to hydroquinone in the treatment of Melasma
title_sort Benefits of using methimazole in comparison to hydroquinone in the treatment of Melasma
author Fernandes, Fernanda Novaes
author_facet Fernandes, Fernanda Novaes
Vieira, Gisllainy Aguiar
Santos , Jeane Rocha
author_role author
author2 Vieira, Gisllainy Aguiar
Santos , Jeane Rocha
author2_role author
author
dc.contributor.author.fl_str_mv Fernandes, Fernanda Novaes
Vieira, Gisllainy Aguiar
Santos , Jeane Rocha
dc.subject.por.fl_str_mv Metimazole
Melasma
Hydroquinone.
Metimazol
Melasma
Hidroquinona.
Metimazol
Melasma
Hidroquinona.
topic Metimazole
Melasma
Hydroquinone.
Metimazol
Melasma
Hidroquinona.
Metimazol
Melasma
Hidroquinona.
description Facial hyperchromias are pigmentary disorders caused by an increase in melanin in a specific area of ​​the skin. Melasma is an acquired hyperchromia, clinically diagnosed, with a high rate of recurrence. Its etiopathogenesis is not fully known, including several factors that facilitate its appearance or aggravate the problem, including exposure to UV rays, genetics, pregnancy, hormonal therapies, among others. Treatment is still a challenge and for many years hydroquinone was one of the most used substances as a tyrosinase inhibitor, but it has many toxic and harmful effects on the skin and other organs. Some alternative treatments with other depigmenting agents, such as metthimazole, also for topical use, have been increasingly effective and with fewer side effects when compared to hydroquinone. This is a literature review study that consists of the existence of two objectives, which are to contextualize a problem and verify existing possibilities in the literature in the formation of the theoretical framework. Furthermore, it is a descriptive exploratory research. Articles that present melasma with the main theme and that have been published between 2009 and 2020 will be selected. Those articles published before 2009 and that have no connection with the topic will be excluded. Conclusion: the study concluded that methimazole use is safer and more effective when compared to hydroquinone, but has slower results. The importance of further research evaluating the safety and efficacy of topical methimazole use is emphasized.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-16
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/24038
10.33448/rsd-v10i16.24038
url https://rsdjournal.org/index.php/rsd/article/view/24038
identifier_str_mv 10.33448/rsd-v10i16.24038
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/24038/21126
dc.rights.driver.fl_str_mv Copyright (c) 2021 Fernanda Novaes Fernandes; Gisllainy Aguiar Vieira; Jeane Rocha Santos 
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Fernanda Novaes Fernandes; Gisllainy Aguiar Vieira; Jeane Rocha Santos 
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 16; e473101624038
Research, Society and Development; Vol. 10 Núm. 16; e473101624038
Research, Society and Development; v. 10 n. 16; e473101624038
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052698969767936